Preparation, characterization and evaluation of [125I]-pirarubicin: a new therapeutic agent for urinary bladder cancer with potential for use as theranostic agent
OA El-Kawy - Applied Radiation and Isotopes, 2022 - Elsevier
Improving urinary bladder cancer diagnosis, follow-up, and therapy tools to overcome
existing limitations and increase survival rates is a highly desirable goal. In the current …
existing limitations and increase survival rates is a highly desirable goal. In the current …
Preparation, characterization and evaluation of [125I]-pirarubicin: A new therapeutic agent for urinary bladder cancer with potential for use as theranostic agent
OA El-Kawy, G Abdelaziz - Applied radiation and …, 2022 - pubmed.ncbi.nlm.nih.gov
Improving urinary bladder cancer diagnosis, follow-up, and therapy tools to overcome
existing limitations and increase survival rates is a highly desirable goal. In the current …
existing limitations and increase survival rates is a highly desirable goal. In the current …
Preparation, characterization and evaluation of [125I]-pirarubicin: A new therapeutic agent for urinary bladder cancer with potential for use as theranostic agent.
OA El-Kawy, G Abdelaziz - … , Instrumentation and Methods for use in …, 2021 - europepmc.org
Improving urinary bladder cancer diagnosis, follow-up, and therapy tools to overcome
existing limitations and increase survival rates is a highly desirable goal. In the current …
existing limitations and increase survival rates is a highly desirable goal. In the current …
Preparation, characterization and evaluation of [125I]-pirarubicin: A new therapeutic agent for urinary bladder cancer with potential for use as theranostic agent
OA El-Kawy, G Abdelaziz - Applied Radiation and Isotopes, 2022 - Elsevier
Improving urinary bladder cancer diagnosis, follow-up, and therapy tools to overcome
existing limitations and increase survival rates is a highly desirable goal. In the current …
existing limitations and increase survival rates is a highly desirable goal. In the current …
Preparation, characterization and evaluation of [125I]-pirarubicin: A new therapeutic agent for urinary bladder cancer with potential for use as theranostic agent
OA El-Kawy, G Abdelaziz - Applied Radiation and Isotopes, 2022 - ui.adsabs.harvard.edu
Improving urinary bladder cancer diagnosis, follow-up, and therapy tools to overcome
existing limitations and increase survival rates is a highly desirable goal. In the current …
existing limitations and increase survival rates is a highly desirable goal. In the current …